EPS Bio Technology Corp. (TPEX:4183)
Taiwan · Delayed Price · Currency is TWD 16.15
+0.15 (0.94%)
Jan 22, 2026, 12:57 PM CST
EPS Bio Technology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 497.19 | 451.08 | 470.17 | 463.45 | 480.28 | 477.6 | Upgrade | |
Revenue Growth (YoY) | 2.51% | -4.06% | 1.45% | -3.50% | 0.56% | 3.97% | Upgrade |
Cost of Revenue | 421.63 | 354.82 | 354.46 | 356.04 | 359.61 | 342.85 | Upgrade |
Gross Profit | 75.56 | 96.27 | 115.71 | 107.42 | 120.67 | 134.75 | Upgrade |
Selling, General & Admin | 58.51 | 59.32 | 57.41 | 57.92 | 54.13 | 58.92 | Upgrade |
Research & Development | 33.49 | 33.43 | 33.22 | 30.88 | 32.28 | 30.39 | Upgrade |
Operating Expenses | 93.27 | 90.87 | 90.79 | 91.4 | 87.61 | 90.59 | Upgrade |
Operating Income | -17.71 | 5.4 | 24.92 | 16.01 | 33.06 | 44.16 | Upgrade |
Interest Expense | -1.93 | -2.05 | -2.14 | -2.13 | -2.18 | -2.29 | Upgrade |
Interest & Investment Income | 1.25 | 2.75 | 2.58 | 0.22 | 0.09 | 0.54 | Upgrade |
Currency Exchange Gain (Loss) | -1.47 | 11.35 | 0.97 | 13.15 | -7.55 | -2.52 | Upgrade |
Other Non Operating Income (Expenses) | 0.38 | 0.36 | 0.39 | 0.21 | 0.11 | 0.19 | Upgrade |
EBT Excluding Unusual Items | -19.48 | 17.81 | 26.72 | 27.46 | 23.52 | 40.07 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -0.26 | - | - | - | Upgrade |
Pretax Income | -19.48 | 17.81 | 26.46 | 27.46 | 23.52 | 40.07 | Upgrade |
Income Tax Expense | -5.24 | 0.5 | 5.47 | 2.1 | 4.88 | 8.37 | Upgrade |
Net Income | -14.24 | 17.31 | 20.99 | 25.36 | 18.64 | 31.7 | Upgrade |
Net Income to Common | -14.24 | 17.31 | 20.99 | 25.36 | 18.64 | 31.7 | Upgrade |
Net Income Growth | - | -17.54% | -17.24% | 36.06% | -41.20% | 71.93% | Upgrade |
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade |
Shares Change (YoY) | -0.05% | -0.08% | -0.10% | 0.03% | -0.13% | 0.18% | Upgrade |
EPS (Basic) | -0.60 | 0.73 | 0.88 | 1.07 | 0.78 | 1.33 | Upgrade |
EPS (Diluted) | -0.60 | 0.73 | 0.88 | 1.06 | 0.78 | 1.33 | Upgrade |
EPS Growth | - | -17.36% | -16.98% | 35.90% | -41.35% | 72.73% | Upgrade |
Free Cash Flow | -18.23 | -46.24 | 45.69 | -9.96 | 20.34 | 73.42 | Upgrade |
Free Cash Flow Per Share | -0.77 | -1.94 | 1.91 | -0.42 | 0.85 | 3.07 | Upgrade |
Dividend Per Share | 0.670 | 0.670 | 0.800 | 0.980 | 0.700 | 1.200 | Upgrade |
Dividend Growth | -16.25% | -16.25% | -18.37% | 40.00% | -41.67% | 71.43% | Upgrade |
Gross Margin | 15.20% | 21.34% | 24.61% | 23.18% | 25.12% | 28.21% | Upgrade |
Operating Margin | -3.56% | 1.20% | 5.30% | 3.45% | 6.88% | 9.25% | Upgrade |
Profit Margin | -2.86% | 3.84% | 4.46% | 5.47% | 3.88% | 6.64% | Upgrade |
Free Cash Flow Margin | -3.67% | -10.25% | 9.72% | -2.15% | 4.23% | 15.37% | Upgrade |
EBITDA | -7.18 | 15.66 | 35.9 | 28.72 | 47.01 | 57.41 | Upgrade |
EBITDA Margin | -1.44% | 3.47% | 7.64% | 6.20% | 9.79% | 12.02% | Upgrade |
D&A For EBITDA | 10.53 | 10.26 | 10.98 | 12.71 | 13.96 | 13.25 | Upgrade |
EBIT | -17.71 | 5.4 | 24.92 | 16.01 | 33.06 | 44.16 | Upgrade |
EBIT Margin | -3.56% | 1.20% | 5.30% | 3.45% | 6.88% | 9.25% | Upgrade |
Effective Tax Rate | - | 2.80% | 20.67% | 7.64% | 20.76% | 20.89% | Upgrade |
Advertising Expenses | - | 3.03 | - | - | - | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.